Katie Coleman: Excited to hear about OncoPrimary as an emerging field

Katie Coleman shared a post on X:

“One of the single most difficult corners of my care pre-diagnosis, through active treatment and into post-treatment/surveillance. Excited to hear about OncoPrimary as an emerging field. Excellent session and such an unmet need for so many.”

Source: Katie Coleman/X

Katie Coleman, Product and Engineering Lead at the Rare Cancer Research Foundation and President of the Chromophobe and Oncocytic Tumor Alliance (COA), is a dedicated software engineer with a mission for creating intuitive, user-friendly products.

As a rare kidney cancer survivor, she is deeply committed to medical research and advocacy. Her personal experience helps her to promote collaborations that advance rare cancer research.